Cellia Science, Inc.
Fayetteville, AR · Founded 2021 · CIK 0001953863 · Medtech · Private
Label-free deep UV imaging device with microfluidic cartridge for automated blood cell differential and platelet counting at point-of-care
- Grants
- $3.0M
- 7 awards
- Sector median: 1
- Raised
- $300K
- 2 Form D · May 2023
- 40 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 1
- 0 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $250,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Microfluidic Cartridge for Point-of-Care Hematology Analysis | $275,985 | |
| Private capital raised | Form D · SEC | $50,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Deep-UV Microscopy for Real-Time Adequacy Analysis of Bone Marrow Aspirates | $275,766 | |
| Federal grant | Department of Health and Human Services · Phase I · Deep-UV Microscopy for Real-Time Adequacy Analysis of Bone Marrow Aspirates | $140,879 | |
| Federal grant | Department of Health and Human Services · Phase I · Deep-UV Microscopy for Real-Time Adequacy Analysis of Bone Marrow Aspirates | $6,500 | |
| Federal grant | Department of Health and Human Services · Phase II · Deep-UV Microscopy for Real-Time Adequacy Analysis of Bone Marrow Aspirates | $1,074,143 | |
| Federal grant | Department of Health and Human Services · Phase I · Point-of-Care Diagnostic for Spontaneous Bacterial Peritonitis | $306,872 | |
| Federal grant | Department of Health and Human Services · Phase II · Deep-UV Microscopy for Real-Time Adequacy Analysis of Bone Marrow Aspirates | $927,466 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1272 | RD RESEARCH TECHNOLOGY USA LLC | — | — |
| 1273 | Cardiio, Inc. | — | — |
| 1274 | HYPERMELT, LLC | — | — |
| 1275 | Cellia Science, Inc. | — | $300K |
| 1276 | PIEZO ENERGY TECHNOLOGIES, LLC | — | — |
| 1277 | NEOFLUIDICS, LLC | — | — |
| 1278 | Balanced Pharma Inc | — | $3.2M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Michael ArtingerDirector
- Fenel EloiDirector
- Calvin GoforthDirector
- Kelly MabryExecutive Officer
- Mark WagstaffExecutive Officer
Patents
- Methods And Systems For Assessment Of Biological Specimen Adequacyapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.